General Information of Drug Off-Target (DOT) (ID: OTGQ8UH7)

DOT Name Arf-GAP with dual PH domain-containing protein 2 (ADAP2)
Synonyms Centaurin-alpha-2; Cnt-a2
Gene Name ADAP2
Related Disease
Advanced cancer ( )
Malignant peripheral nerve sheath tumor ( )
Neurofibroma ( )
Neurofibromatosis type 1 ( )
UniProt ID
ADAP2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF01412 ; PF00169
Sequence
MGDRERNKKRLLELLRAPDTGNAHCADCGAADPDWASYKLGIFICLNCCGVHRNFPDISR
VKSVRLDFWDDSIVEFMIHNGNLRVKAKFEARVPAFYYIPQANDCLVLKEQWIRAKYERR
EFMADGETISLPGNREGFLWKRGRDNSQFLRRKFVLLAREGLLKYFTKEQGKSPKAVISI
KDLNATFQTEKIGHPHGLQITYRRDGHTRNLFVYHESGKEIVDWFNALRAARLQYLKMAF
PELPESELVPFLTRNYLKQGFMEKTGPKQKEPFKKRWFALDCHERRLLYYKNPLDAFEQG
QVFLGNKEQGYEAYEDLPKGIRGNRWKAGLTIVTPERRFVLTCPSEKEQQEWLESLRGVL
SSPLTPLNRLTASTESGRSSR
Function
GTPase-activating protein for the ADP ribosylation factor family (Potential). Binds phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) and inositol 1,3,4,5-tetrakisphosphate (InsP4). Possesses a stoichiometry of two binding sites for InsP4 with identical affinity.
Tissue Specificity
Highly expressed in placenta, spleen, kidney, skeletal muscle and adrenal gland. Weakly expressed in thyroid, liver, heart, lung, small intestine, peripheral blood leukocytes. Not detected in spinal cord, brain, stomach, trachea, colon, lymph node and bone marrow.

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Genetic Variation [1]
Malignant peripheral nerve sheath tumor DIS0JTN6 Strong Biomarker [1]
Neurofibroma DISIJJMH Strong Biomarker [2]
Neurofibromatosis type 1 DIS53JH9 moderate Genetic Variation [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
12 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [4]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [5]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [6]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [7]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [8]
Arsenic DMTL2Y1 Approved Arsenic decreases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [9]
Hydroquinone DM6AVR4 Approved Hydroquinone increases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [10]
Sodium lauryl sulfate DMLJ634 Approved Sodium lauryl sulfate decreases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [11]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [12]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [13]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [14]
Taurine DMVW7N3 Investigative Taurine increases the expression of Arf-GAP with dual PH domain-containing protein 2 (ADAP2). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Drug(s)

References

1 Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients.Mol Med. 2011 Jan-Feb;17(1-2):79-87. doi: 10.2119/molmed.2010.00079. Epub 2010 Sep 10.
2 Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation.Neurogenetics. 2009 Feb;10(1):79-85. doi: 10.1007/s10048-008-0154-0. Epub 2008 Oct 11.
3 Identification of gene structure and subcellular localization of human centaurin alpha 2, and p42IP4, a family of two highly homologous, Ins 1,3,4,5-P4-/PtdIns 3,4,5-P3-binding, adapter proteins.J Neurochem. 2004 Jan;88(2):326-36. doi: 10.1046/j.1471-4159.2003.02143.x.
4 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
5 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
6 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
7 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
8 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
9 Arsenic exposure from drinking water is associated with decreased gene expression and increased DNA methylation in peripheral blood. Toxicol Appl Pharmacol. 2017 Apr 15;321:57-66. doi: 10.1016/j.taap.2017.02.019. Epub 2017 Feb 24.
10 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
11 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
12 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
13 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
14 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
15 Taurine-responsive genes related to signal transduction as identified by cDNA microarray analyses of HepG2 cells. J Med Food. 2006 Spring;9(1):33-41. doi: 10.1089/jmf.2006.9.33.